Professor Declan G Murphy
Professor Declan G Murphy
Peter MacCallum Cancer Centre
Verified email at - Homepage
Cited by
Cited by
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised …
MS Hofman, N Lawrentschuk, RJ Francis, C Tang, I Vela, P Thomas, ...
The Lancet 395 (10231), 1208-1216, 2020
Sensitivity, specificity, and predictors of positive 68Ga–prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and …
M Perera, N Papa, D Christidis, D Wetherell, MS Hofman, DG Murphy, ...
European urology 70 (6), 926-937, 2016
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
MS Hofman, J Violet, RJ Hicks, J Ferdinandus, SP Thang, T Akhurst, ...
The Lancet Oncology 19 (6), 825-833, 2018
Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution …
M Perera, N Papa, M Roberts, M Williams, C Udovicich, I Vela, ...
European urology 77 (4), 403-417, 2020
State-of-the-art in force and tactile sensing for minimally invasive surgery
P Puangmali, K Althoefer, LD Seneviratne, D Murphy, P Dasgupta
IEEE Sensors Journal 8 (4), 371-381, 2008
Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy
G Novara, JWF Catto, T Wilson, M Annerstedt, K Chan, DG Murphy, ...
European urology 67 (3), 376-401, 2015
Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019
S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ...
European urology 77 (4), 508-547, 2020
Dosimetry of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes
J Violet, P Jackson, J Ferdinandus, S Sandhu, T Akhurst, A Iravani, ...
Journal of Nuclear Medicine 60 (4), 517-523, 2019
Laparoscopic and robotic‐assisted versus open radical prostatectomy for the treatment of localised prostate cancer
D Ilic, SM Evans, CA Allan, JH Jung, D Murphy, M Frydenberg
Cochrane Database of Systematic Reviews, 2017
Stereotactic abative body radiotherapy (SABR) for oligometastatic prostate cancer: a prospective clinical trial
S Siva, M Bressel, DG Murphy, M Shaw, S Chander, J Violet, KH Tai, ...
European urology 74 (4), 455-462, 2018
Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?
JP Grummet, M Weerakoon, S Huang, N Lawrentschuk, M Frydenberg, ...
BJU international 114 (3), 384-388, 2014
The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the …
L Emmett, J Buteau, N Papa, D Moon, J Thompson, MJ Roberts, K Rasiah, ...
European urology 80 (6), 682-689, 2021
Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data …
NJ Sathianathen, A Omer, E Harriss, L Davies, V Kasivisvanathan, ...
European urology 78 (3), 402-414, 2020
Long-term follow-up and outcomes of retreatment in an expanded 50-patient single-center phase II prospective trial of 177Lu-PSMA-617 theranostics in metastatic castration …
J Violet, S Sandhu, A Iravani, J Ferdinandus, SP Thang, G Kong, ...
Journal of Nuclear Medicine 61 (6), 857-865, 2020
Robotic versus laparoscopic proctectomy for rectal cancer: a meta-analysis
S Memon, AG Heriot, DG Murphy, M Bressel, AC Lynch
Annals of surgical oncology 19, 2095-2101, 2012
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories
RA Taylor, M Fraser, J Livingstone, SMG Espiritu, H Thorne, V Huang, ...
Nature communications 8 (1), 13671, 2017
Operative details and oncological and functional outcome of robotic-assisted laparoscopic radical prostatectomy: 400 cases with a minimum of 12 months follow-up
DG Murphy, M Kerger, H Crowe, JS Peters, AJ Costello
European urology 55 (6), 1358-1367, 2009
Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers
EC Page, EK Bancroft, MN Brook, M Assel, MH Al Battat, S Thomas, ...
European urology 76 (6), 831-842, 2019
The social media revolution is changing the conference experience: analytics and trends from eight international meetings
SE Wilkinson, MY Basto, G Perovic, N Lawrentschuk, DG Murphy
BJU international 115 (5), 839-846, 2015
Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel
TG Wilson, K Guru, RC Rosen, P Wiklund, M Annerstedt, BH Bochner, ...
European urology 67 (3), 363-375, 2015
The system can't perform the operation now. Try again later.
Articles 1–20